2020
DOI: 10.3389/fpls.2020.01126
|View full text |Cite
|
Sign up to set email alerts
|

CRISPR/Cas9 Gene Editing: An Unexplored Frontier for Forest Pathology

Abstract: CRISPR/Cas9 gene editing technology has taken the scientific community by storm since its development in 2012. First discovered in 1987, CRISPR/Cas systems act as an adaptive immune response in archaea and bacteria that defends against invading bacteriophages and plasmids. CRISPR/Cas9 gene editing technology modifies this immune response to function in eukaryotic cells as a highly specific, RNA-guided complex that can edit almost any genetic target. This technology has applications in all biological fields, in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
20
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(20 citation statements)
references
References 137 publications
(215 reference statements)
0
20
0
Order By: Relevance
“…Marker-Assisted Selection-MAS (Butcher and Southerton, 2007;Muranty et al, 2014) and Backcrossing-MAB (Herzog and Frisch, 2011) provide frameworks to pyramid target genetic variants of simple Mendelian traits, which are those regulated by few major genes (e.g., resistance to biotic stresses). Gene editing (Doudna and Charpentier, 2014;Dort et al, 2020) and transgenics (Campbell et al, 2003) can also transfer or silence allelic variants of major effects within a single generation (Pereira-Lorenzo et al, 2019). These may replicate the success of tolerant chestnuts (Alcaide et al, 2019a;Westbrook et al, 2019) and promote reproductive sterility (Meilan et al, 2001;Fritsche et al, 2018).…”
Section: Predictive Breeding Promises Boosting Forest Tree Genetic Immentioning
confidence: 99%
“…Marker-Assisted Selection-MAS (Butcher and Southerton, 2007;Muranty et al, 2014) and Backcrossing-MAB (Herzog and Frisch, 2011) provide frameworks to pyramid target genetic variants of simple Mendelian traits, which are those regulated by few major genes (e.g., resistance to biotic stresses). Gene editing (Doudna and Charpentier, 2014;Dort et al, 2020) and transgenics (Campbell et al, 2003) can also transfer or silence allelic variants of major effects within a single generation (Pereira-Lorenzo et al, 2019). These may replicate the success of tolerant chestnuts (Alcaide et al, 2019a;Westbrook et al, 2019) and promote reproductive sterility (Meilan et al, 2001;Fritsche et al, 2018).…”
Section: Predictive Breeding Promises Boosting Forest Tree Genetic Immentioning
confidence: 99%
“…Therefore, genetic modification (GM) provides the potential for transformation in shorter timeframes but is challenged by existing genetically modified organism (GMO) laws. Genome editing (GE), which may generate mutations in sites, allows for the fast implementation of specific changes and is less restricted worldwide than genetically modified technology [ 240 , 241 ]. Genome engineering in forestry is urgently needed given the rise in human activity and the effects of climate change (for instance, changes in rainfall distribution and the increase in severe droughts).…”
Section: Genome-wide Association Studies (Gwas)mentioning
confidence: 99%
“…These studies suggest that the sequence context at or near the target sites may affect mutagenesis results. Available findings indicate persistent CRISPR-induced mutations and related phenotypes across many clonal generations enabling commercial production of elite trees propagated vegetatively [ 240 , 258 , 266 ].…”
Section: Genome-wide Association Studies (Gwas)mentioning
confidence: 99%
See 1 more Smart Citation
“…In October 2020, the Nobel Committee announced the award of Nobel Prize in Chemistry to Dr. Emmanuelle Charpentier and Dr. Jennifer Doudna for their pioneering work in precise genome editing with the clustered regularly interspaced short palindromic repeats (CRISPR) technology. The basic features of CRISPR were first recognized by Japanese scientists in 1987 and officially termed as “CRISPR” in 2002, but it was not further developed until the early 2000s, when it was used as a powerful genome editing platform [ 1 , 2 ]. This technology allows exceptionally precise genome editing in a wide range of species and extends our ability to investigate the contribution of genetic factors to various unexplained phenotypes and diseases.…”
mentioning
confidence: 99%